financetom
Business
financetom
/
Business
/
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
Jul 24, 2024 4:34 AM

07:02 AM EDT, 07/24/2024 (MT Newswires) -- Travel + Leisure ( TNL ) reported Q2 adjusted earnings Wednesday of $1.52 per diluted share, up from $1.33 a year earlier.

Analysts polled by Capital IQ expected $1.41.

Net revenue for the quarter ended on June 30 was $985 million, up from $949 million a year earlier.

Analysts surveyed by Capital IQ expected $987.2 million.

The company expects Q3 adjusted EBITDA of $235 million to $245 million. Analysts polled by Capital IQ expect $238.7 million. The company updated its full-year adjusted EBITDA to a new range of $915 million to $935 million versus the prior outlook of $910 million to $930 million. Analysts polled by Capital IQ expect $921.6 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Digi Power X to Raise $15 Million in Registered Direct Offering; Shares Down
Digi Power X to Raise $15 Million in Registered Direct Offering; Shares Down
Jul 21, 2025
08:26 AM EDT, 07/21/2025 (MT Newswires) -- Digi Power X ( DGXX ) said Monday that it has agreed to sell 4.8 million shares at $3.12 each to a new institutional investor in a registered direct offering. The offering is slated to be completed on or around Tuesday, subject to TSX Venture Exchange approval and customary conditions, the company said....
Johnson & Johnson Files FDA Application for Oral Psoriasis Drug Candidate Icotrokinra
Johnson & Johnson Files FDA Application for Oral Psoriasis Drug Candidate Icotrokinra
Jul 21, 2025
08:27 AM EDT, 07/21/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday it has submitted a new drug application to the US Food and Drug Administration seeking the first approval of icotrokinra, which is intended for the treatment of adults and pediatric patients aged 12 years and older with moderate to severe plaque psoriasis. The application included...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
MGP Ingredients Names Julie Francis as President, CEO
MGP Ingredients Names Julie Francis as President, CEO
Jul 21, 2025
08:27 AM EDT, 07/21/2025 (MT Newswires) -- MGP Ingredients ( MGPI ) said Monday its board appointed Julie Francis as the company's president and chief executive officer, effective immediately. Francis takes over from Interim President and CEO Brandon Gall, who served in the role since January 1 and will continue as the company's chief financial officer, according to a statement....
Copyright 2023-2026 - www.financetom.com All Rights Reserved